Lista de obras -

A man in his 60s with severe respiratory failure ⬇️

artículo científico publicado el 6 de septiembre de 2011

An interleukin-6 (IL-6) receptor polymorphism affecting serum levels of IL-6 does not increase the risk of cholangiocarcinoma in primary sclerosing cholangitis

scientific article published on 01 April 2008

Analysis of MAdCAM-1 and ICAM-1 polymorphisms in 365 Scandinavian patients with primary sclerosing cholangitis

artículo científico publicado en 2006

Antineutrophil antibodies define clinical and genetic subgroups in primary sclerosing cholangitis

artículo científico publicado en 2016

Association Between HLA Haplotypes and Increased Serum Levels of IgG4 in Patients With Primary Sclerosing Cholangitis

artículo científico publicado en 2015

Association analysis of the 1858C>T polymorphism in the PTPN22 gene in juvenile idiopathic arthritis and other autoimmune diseases

artículo científico publicado en 2005

Association between reduced levels of alkaline phosphatase and survival times of patients with primary sclerosing cholangitis

artículo científico publicado en 2013

Association of UCP2 -866 G/A polymorphism with chronic inflammatory diseases

artículo científico publicado en 2009

Association of matrix metalloproteinase-1 and -3 promoter polymorphisms with clinical subsets of Norwegian primary sclerosing cholangitis patients

artículo científico publicado en 2004

Association of the tumour necrosis factor alpha -308 but not the interleukin 10 -627 promoter polymorphism with genetic susceptibility to primary sclerosing cholangitis.

artículo científico publicado en 2001

Autotaxin activity predicts transplant-free survival in primary sclerosing cholangitis.

artículo científico publicado en 2019

Biliary dysplasia as a marker of cholangiocarcinoma in primary sclerosing cholangitis

artículo científico publicado en 2001

Cancer After Liver Transplantation in Children and Young Adults: A Population-Based Study From 4 Nordic Countries

scientific article published on 01 September 2018

Cancer Risk and Surveillance in Primary Sclerosing Cholangitis

artículo científico

Catalytically impaired hMYH and NEIL1 mutant proteins identified in patients with primary sclerosing cholangitis and cholangiocarcinoma

artículo científico publicado en 2009

Cholangiocarcinoma in primary sclerosing cholangitis is associated with NKG2D polymorphisms

scientific article published on 01 January 2008

Cholangiocarcinoma in primary sclerosing cholangitis: K-ras mutations and Tp53 dysfunction are implicated in the neoplastic development

scientific article published on 01 March 2000

Cholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical presentation.

artículo científico publicado en 2002

Cholangiocarcinoma in situ in primary sclerosing cholangitis: diagnosis by brush cytology and treatment by liver transplantation

artículo científico publicado en 2003

Cholangiocarcinoma is associated with a raised enhanced liver fibrosis score independent of primary sclerosing cholangitis

scientific article published on 18 March 2019

Colectomy for patients with ulcerative colitis and primary sclerosing cholangitis - what next?

artículo científico publicado en 2013

Colorectal neoplasia in patients with primary sclerosing cholangitis undergoing liver transplantation: a Nordic multicenter study

artículo científico publicado en 2012

Comprehensive assessment of ECM turnover using serum biomarkers establishes PBC as a high-turnover autoimmune liver disease

artículo científico publicado en 2020

Decreasing incidence of cancer after liver transplantation-A Nordic population-based study over 3 decades

artículo científico publicado en 2017

Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis.

artículo científico publicado en 2013

Detection of antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis: a comparison of the alkaline phosphatase and immunofluorescent techniques ⬇️

artículo científico publicado el 1 de junio de 1997

Diagnosis and management of primary sclerosing cholangitis

artículo científico publicado en 2010

Diagnosis and treatment of cholangiocarcinoma

artículo científico publicado en 2004

Diagnostic accuracy of magnetic resonance and endoscopic retrograde cholangiography in primary sclerosing cholangitis

scientific article published on 01 April 2006

Diagnostic benefit of biliary brush cytology in cholangiocarcinoma in primary sclerosing cholangitis

artículo científico publicado en 2006

Differences in long-term survival among liver transplant recipients and the general population: a population-based Nordic study.

artículo científico

Different HLA class II associations in ulcerative colitis patients with and without primary sclerosing cholangitis

scientific article published on 15 February 2007

Early bedside detection of ischemia and rejection in liver transplants by microdialysis

artículo científico publicado en 2012

Effects of coffee consumption, smoking, and hormones on risk for primary sclerosing cholangitis

artículo científico publicado en 2013

Electrostatic modifications of the human leukocyte antigen-DR P9 peptide-binding pocket and susceptibility to primary sclerosing cholangitis

artículo científico publicado en 2011

Elevated trimethylamine-N-oxide (TMAO) is associated with poor prognosis in primary sclerosing cholangitis patients with normal liver function

artículo científico publicado en 2016

Endoscopic treatment for primary sclerosing cholangitis?

artículo científico publicado en 2002

Enhanced liver fibrosis score predicts transplant-free survival in primary sclerosing cholangitis

artículo científico publicado en 2015

Enhanced liver fibrosis test predicts transplant-free survival in primary sclerosing cholangitis, a multi-centre study

artículo científico publicado en 2017

Epidemiology of primary sclerosing cholangitis

artículo científico publicado en 2001

Etiology and pathogenesis in primary sclerosing cholangitis.

artículo científico publicado en 1994

Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA).

artículo científico publicado en 2016

Extended analysis of a genome-wide association study in primary sclerosing cholangitis detects multiple novel risk loci

artículo científico publicado en 2012

FUT2 and FUT3 genotype determines CA19-9 cut-off values for detection of cholangiocarcinoma in patients with primary sclerosing cholangitis

article

Features of autoimmune hepatitis in primary sclerosing cholangitis: an evaluation of 114 primary sclerosing cholangitis patients according to a scoring system for the diagnosis of autoimmune hepatitis

artículo científico publicado en 1996

Four DNA methylation biomarkers in biliary brush samples accurately identify the presence of cholangiocarcinoma

artículo científico publicado en 2015

Gallbladder polyps in primary sclerosing cholangitis: not so benign

artículo científico publicado en 2008

Genetic association analysis identifies variants associated with disease progression in primary sclerosing cholangitis

artículo científico publicado en 2017

Genetic polymorphisms associated with inflammatory bowel disease do not confer risk for primary sclerosing cholangitis

artículo científico publicado en 2006

Genome-wide association analysis in primary sclerosing cholangitis

artículo científico publicado en 2009

Genome-wide association analysis in primary sclerosing cholangitis and ulcerative colitis identifies risk loci at GPR35 and TCF4

scientific journal article

Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci

scientific journal article

Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease

artículo científico publicado en 2016

Genomic characterization of cholangiocarcinoma in primary sclerosing cholangitis reveals novel therapeutic opportunities

scientific article published on 10 January 2020

Gut and liver T-cells of common clonal origin in primary sclerosing cholangitis-inflammatory bowel disease

artículo científico publicado en 2016

HLA class II haplotypes in primary sclerosing cholangitis patients from five European populations

artículo científico publicado en 1999

HLA variants related to primary sclerosing cholangitis influence rejection after liver transplantation.

scientific article published on April 2014

Hepatic and extrahepatic malignancies and primary sclerosing cholangitis

artículo científico publicado en 2003

Hepatobiliary disease in ulcerative colitis. An analysis of 18 patients with hepatobiliary lesions classified as small-duct primary sclerosing cholangitis

artículo científico publicado en 1994

High dose ursodeoxycholic acid in primary sclerosing cholangitis does not prevent colorectal neoplasia

artículo científico publicado en 2012

High-dose ursodeoxycholic acid in primary sclerosing cholangitis: a 5-year multicenter, randomized, controlled study

artículo científico publicado en 2005

Immunosuppression after liver transplantation for primary sclerosing cholangitis influences activity of inflammatory bowel disease.

artículo científico publicado en 2013

Indications and Outcomes in Liver Transplantation in Patients With Primary Sclerosing Cholangitis in Norway

artículo científico publicado en 2015

Inflammatory bowel disease in patients with primary sclerosing cholangitis: clinical characterization in liver transplanted and nontransplanted patients

artículo científico publicado en 2011

Inflammatory markers sampled by microdialysis catheters distinguish rejection from ischemia in liver grafts

artículo científico publicado en 2012

Is a prolonged bleeding time associated with an increased risk of hemorrhage after liver biopsy?

scientific article published on 01 March 1999

Liver Transplantation for Nonresectable Liver Metastases From Colorectal Cancer ⬇️

artículo científico publicado el 1 de mayo de 2013

Liver abnormalities in bowel diseases

artículo científico publicado en 2013

Liver transplantation in Norway through 25 years

artículo científico publicado en 2009

Liver transplantation in the Nordic countries - An intention to treat and post-transplant analysis from The Nordic Liver Transplant Registry 1982-2013.

artículo científico publicado en 2015

Liver transplantation with deceased ABO-incompatible donors is life-saving but associated with increased risk of rejection and post-transplant complications

artículo científico publicado en 2015

Long-Term Effect of Corticosteroid Treatment in Primary Sclerosing Cholangitis Patients ⬇️

artículo científico publicado el 1 de septiembre de 2003

Mutational characterization of the bile acid receptor TGR5 in primary sclerosing cholangitis

artículo científico publicado en 2010

No Evidence That Azathioprine Increases Risk of Cholangiocarcinoma in Patients With Primary Sclerosing Cholangitis.

artículo científico publicado en 2016

No major effect of the CD28/CTLA4/ICOS gene region on susceptibility to primary sclerosing cholangitis.

artículo científico publicado en 2006

Novel serum and bile protein markers predict primary sclerosing cholangitis disease severity and prognosis

artículo científico publicado en 2017

Novel target genes and a valid biomarker panel identified for cholangiocarcinoma

artículo científico publicado en 2012

Overlap syndromes: the International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue

artículo científico publicado en 2010

Particular genetic variants of ligands for natural killer cell receptors may contribute to the HLA associated risk of primary sclerosing cholangitis

artículo científico publicado en 2007

Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis

artículo científico publicado en 2017

Patients with small duct primary sclerosing cholangitis have a favourable long term prognosis

artículo científico publicado en 2002

Polymorphisms in the steroid and xenobiotic receptor gene influence survival in primary sclerosing cholangitis

scientific article published on 01 September 2006

Prevalence and epidemiology of autoimmune hepatitis

artículo científico publicado en 2002

Primary sclerosing cholangitis

artículo científico publicado en 2010

Primary sclerosing cholangitis - the Norwegian experience

artículo científico

Primary sclerosing cholangitis and malignancy

artículo científico

Primary sclerosing cholangitis is associated to an extended B8-DR3 haplotype including particular MICA and MICB alleles

artículo científico publicado en 2001

Primary sclerosing cholangitis is associated with extended HLA-DR3 and HLA-DR6 haplotypes

artículo científico publicado en 2007

Primary sclerosing cholangitis: challenges of a new millenium

artículo científico publicado en 2000

Refinement of the MHC risk map in a scandinavian primary sclerosing cholangitis population

artículo científico publicado en 2014

Review article: controversies in the management of primary biliary cirrhosis and primary sclerosing cholangitis

artículo científico

Risk factors and prognosis for recurrent primary sclerosing cholangitis after liver transplantation: a Nordic Multicentre Study

artículo científico publicado en 2018

Serological markers of extracellular matrix remodeling predict transplant-free survival in primary sclerosing cholangitis

artículo científico publicado en 2018

Serum microRNAs as novel biomarkers for primary sclerosing cholangitis and cholangiocarcinoma

artículo científico publicado en 2016

Severe liver failure in exertional heat stroke

artículo científico publicado en 1999

Simplified criteria for the diagnosis of autoimmune hepatitis

artículo científico publicado en 2008

Small duct primary sclerosing cholangitis without inflammatory bowel disease is genetically different from large duct disease

artículo científico publicado en 2014

The 32-base pair deletion of the chemokine receptor 5 gene (CCR5-Delta32) is not associated with primary sclerosing cholangitis in 363 Scandinavian patients

artículo científico publicado en 2006

The FCRL3 -169T>C polymorphism is associated with rheumatoid arthritis and shows suggestive evidence of involvement with juvenile idiopathic arthritis in a Scandinavian panel of autoimmune diseases

artículo científico publicado en 2007

The First European Evidence-based Consensus on Extra-intestinal Manifestations in Inflammatory Bowel Disease

artículo científico publicado en 2015

The HLA-DR3,DQ2 heterozygous genotype is associated with an accelerated progression of primary sclerosing cholangitis

artículo científico publicado en 2001

The natural history of small-duct primary sclerosing cholangitis

artículo científico

The novel colorectal cancer biomarkers CDO1, ZSCAN18 and ZNF331 are frequently methylated across gastrointestinal cancers

artículo científico publicado en 2014

Three ulcerative colitis susceptibility loci are associated with primary sclerosing cholangitis and indicate a role for IL2, REL, and CARD9

artículo científico publicado en 2011

Time-dependent Cox regression model is superior in prediction of prognosis in primary sclerosing cholangitis

scientific article published on 01 March 2002

Treatment of paracetamol poisoning. An indication for liver transplantation?

artículo científico publicado en 1994

Update on primary sclerosing cholangitis

artículo científico publicado en 2013

Update on primary sclerosing cholangitis

artículo científico publicado en 2010

Validation of a cholangiographic prognostic model in primary sclerosing cholangitis

artículo científico publicado en 2010

[Fulminant liver failure in acute hepatitis B virus infection]

artículo científico publicado en 2003

[Treatment of cholestatic liver diseases with ursodeoxycholic acid]

artículo científico publicado en 1997

Lista de obras de

A man in his 60s with severe respiratory failure ⬇️

An interleukin-6 (IL-6) receptor polymorphism affecting serum levels of IL-6 does not increase the risk of cholangiocarcinoma in primary sclerosing cholangitis

Analysis of MAdCAM-1 and ICAM-1 polymorphisms in 365 Scandinavian patients with primary sclerosing cholangitis

Antineutrophil antibodies define clinical and genetic subgroups in primary sclerosing cholangitis

Association Between HLA Haplotypes and Increased Serum Levels of IgG4 in Patients With Primary Sclerosing Cholangitis

Association analysis of the 1858C>T polymorphism in the PTPN22 gene in juvenile idiopathic arthritis and other autoimmune diseases

Association between reduced levels of alkaline phosphatase and survival times of patients with primary sclerosing cholangitis

Association of UCP2 -866 G/A polymorphism with chronic inflammatory diseases

Association of matrix metalloproteinase-1 and -3 promoter polymorphisms with clinical subsets of Norwegian primary sclerosing cholangitis patients

Association of the tumour necrosis factor alpha -308 but not the interleukin 10 -627 promoter polymorphism with genetic susceptibility to primary sclerosing cholangitis.

Autotaxin activity predicts transplant-free survival in primary sclerosing cholangitis.

Biliary dysplasia as a marker of cholangiocarcinoma in primary sclerosing cholangitis

Cancer After Liver Transplantation in Children and Young Adults: A Population-Based Study From 4 Nordic Countries

Cancer Risk and Surveillance in Primary Sclerosing Cholangitis

Catalytically impaired hMYH and NEIL1 mutant proteins identified in patients with primary sclerosing cholangitis and cholangiocarcinoma

Cholangiocarcinoma in primary sclerosing cholangitis is associated with NKG2D polymorphisms

Cholangiocarcinoma in primary sclerosing cholangitis: K-ras mutations and Tp53 dysfunction are implicated in the neoplastic development

Cholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical presentation.

Cholangiocarcinoma in situ in primary sclerosing cholangitis: diagnosis by brush cytology and treatment by liver transplantation

Cholangiocarcinoma is associated with a raised enhanced liver fibrosis score independent of primary sclerosing cholangitis

Colectomy for patients with ulcerative colitis and primary sclerosing cholangitis - what next?

Colorectal neoplasia in patients with primary sclerosing cholangitis undergoing liver transplantation: a Nordic multicenter study

Comprehensive assessment of ECM turnover using serum biomarkers establishes PBC as a high-turnover autoimmune liver disease

Decreasing incidence of cancer after liver transplantation-A Nordic population-based study over 3 decades

Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis.

Detection of antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis: a comparison of the alkaline phosphatase and immunofluorescent techniques ⬇️

Diagnosis and management of primary sclerosing cholangitis

Diagnosis and treatment of cholangiocarcinoma

Diagnostic accuracy of magnetic resonance and endoscopic retrograde cholangiography in primary sclerosing cholangitis

Diagnostic benefit of biliary brush cytology in cholangiocarcinoma in primary sclerosing cholangitis

Differences in long-term survival among liver transplant recipients and the general population: a population-based Nordic study.

Different HLA class II associations in ulcerative colitis patients with and without primary sclerosing cholangitis

Early bedside detection of ischemia and rejection in liver transplants by microdialysis

Effects of coffee consumption, smoking, and hormones on risk for primary sclerosing cholangitis

Electrostatic modifications of the human leukocyte antigen-DR P9 peptide-binding pocket and susceptibility to primary sclerosing cholangitis

Elevated trimethylamine-N-oxide (TMAO) is associated with poor prognosis in primary sclerosing cholangitis patients with normal liver function

Endoscopic treatment for primary sclerosing cholangitis?

Enhanced liver fibrosis score predicts transplant-free survival in primary sclerosing cholangitis

Enhanced liver fibrosis test predicts transplant-free survival in primary sclerosing cholangitis, a multi-centre study

Epidemiology of primary sclerosing cholangitis

Etiology and pathogenesis in primary sclerosing cholangitis.

Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA).

Extended analysis of a genome-wide association study in primary sclerosing cholangitis detects multiple novel risk loci

FUT2 and FUT3 genotype determines CA19-9 cut-off values for detection of cholangiocarcinoma in patients with primary sclerosing cholangitis

Features of autoimmune hepatitis in primary sclerosing cholangitis: an evaluation of 114 primary sclerosing cholangitis patients according to a scoring system for the diagnosis of autoimmune hepatitis

Four DNA methylation biomarkers in biliary brush samples accurately identify the presence of cholangiocarcinoma

Gallbladder polyps in primary sclerosing cholangitis: not so benign

Genetic association analysis identifies variants associated with disease progression in primary sclerosing cholangitis

Genetic polymorphisms associated with inflammatory bowel disease do not confer risk for primary sclerosing cholangitis

Genome-wide association analysis in primary sclerosing cholangitis

Genome-wide association analysis in primary sclerosing cholangitis and ulcerative colitis identifies risk loci at GPR35 and TCF4

Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci

Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease

Genomic characterization of cholangiocarcinoma in primary sclerosing cholangitis reveals novel therapeutic opportunities

Gut and liver T-cells of common clonal origin in primary sclerosing cholangitis-inflammatory bowel disease

HLA class II haplotypes in primary sclerosing cholangitis patients from five European populations

HLA variants related to primary sclerosing cholangitis influence rejection after liver transplantation.

Hepatic and extrahepatic malignancies and primary sclerosing cholangitis

Hepatobiliary disease in ulcerative colitis. An analysis of 18 patients with hepatobiliary lesions classified as small-duct primary sclerosing cholangitis

High dose ursodeoxycholic acid in primary sclerosing cholangitis does not prevent colorectal neoplasia

High-dose ursodeoxycholic acid in primary sclerosing cholangitis: a 5-year multicenter, randomized, controlled study

Immunosuppression after liver transplantation for primary sclerosing cholangitis influences activity of inflammatory bowel disease.

Indications and Outcomes in Liver Transplantation in Patients With Primary Sclerosing Cholangitis in Norway

Inflammatory bowel disease in patients with primary sclerosing cholangitis: clinical characterization in liver transplanted and nontransplanted patients

Inflammatory markers sampled by microdialysis catheters distinguish rejection from ischemia in liver grafts

Is a prolonged bleeding time associated with an increased risk of hemorrhage after liver biopsy?

Liver Transplantation for Nonresectable Liver Metastases From Colorectal Cancer ⬇️

Liver abnormalities in bowel diseases

Liver transplantation in Norway through 25 years

Liver transplantation in the Nordic countries - An intention to treat and post-transplant analysis from The Nordic Liver Transplant Registry 1982-2013.

Liver transplantation with deceased ABO-incompatible donors is life-saving but associated with increased risk of rejection and post-transplant complications

Long-Term Effect of Corticosteroid Treatment in Primary Sclerosing Cholangitis Patients ⬇️

Mutational characterization of the bile acid receptor TGR5 in primary sclerosing cholangitis

No Evidence That Azathioprine Increases Risk of Cholangiocarcinoma in Patients With Primary Sclerosing Cholangitis.

No major effect of the CD28/CTLA4/ICOS gene region on susceptibility to primary sclerosing cholangitis.

Novel serum and bile protein markers predict primary sclerosing cholangitis disease severity and prognosis

Novel target genes and a valid biomarker panel identified for cholangiocarcinoma

Overlap syndromes: the International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue

Particular genetic variants of ligands for natural killer cell receptors may contribute to the HLA associated risk of primary sclerosing cholangitis